1. Home
  2. IDT vs MDXG Comparison

IDT vs MDXG Comparison

Compare IDT & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IDT Corporation Class B

IDT

IDT Corporation Class B

HOLD

Current Price

$51.79

Market Cap

1.2B

ML Signal

HOLD

Logo MiMedx Group Inc

MDXG

MiMedx Group Inc

HOLD

Current Price

$7.03

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IDT
MDXG
Founded
1990
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
IDT
MDXG
Price
$51.79
$7.03
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$11.00
AVG Volume (30 Days)
248.4K
776.2K
Earning Date
12-04-2025
10-29-2025
Dividend Yield
0.47%
N/A
EPS Growth
10.35
N/A
EPS
3.22
0.27
Revenue
$1,244,681,000.00
$393,442,000.00
Revenue This Year
$0.77
$19.13
Revenue Next Year
N/A
$2.11
P/E Ratio
$15.98
$26.10
Revenue Growth
2.52
14.77
52 Week Low
$44.77
$5.79
52 Week High
$71.12
$9.71

Technical Indicators

Market Signals
Indicator
IDT
MDXG
Relative Strength Index (RSI) 54.28 49.48
Support Level $50.60 $6.62
Resistance Level $54.08 $7.45
Average True Range (ATR) 2.08 0.26
MACD 0.27 0.02
Stochastic Oscillator 66.08 45.22

Price Performance

Historical Comparison
IDT
MDXG

About IDT IDT Corporation Class B

IDT Corp is a multinational holding company. It operates in the telecommunications and payment industries. It has four reportable business segments, Fintech, National Retail Solutions; net2phone and Traditional Communications, The Fintech segment is comprised of National Retail Solutions (NRS), an operator of a nationwide point of sale (POS) network providing payment processing, digital advertising, transaction data, and ancillary services, and BOSS Money, a provider of international money remittance and related value/payment transfer services. The net2phone segment provides unified cloud communications and telephony services to business customers.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: